$REPL 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 to develop the next generation of oncolytic immune-gene therapies for the treatment of cancer. Replimune is developing novel, proprietary therapeutics intended to improve the direct cancer-killing effects of selective virus replication and the potency of the immune response to the tumor antigens released. Replimune's Immulytic™ platform is designed to maximize systemic immune activation, in particular to tumor neoantigens, through robust viral-mediated immunogenic tumor cell killing and the delivery of optimal combinations of immune-activating proteins to the tumor and draining lymph nodes. The approach is expected to be highly synergistic with immune checkpoint blockade and other approaches to cancer treatment across a broad range of cancers. Replimune intends to progress these therapies rapidly through clinical development in combination with other immuno-oncology products with complementary mechanisms of action as well as in standalone indications.

CEO

philip Astley-Sparke

Exchange

NASDAQ

Website

www.replimune.com

$M

Total Revenue

152

Employees

$2B

Market Capitalization

-17.71

Price/Earning ratio

Industry Peers

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Charles River Laboratories Int CRL 22463 3273 9.58 56.69 12.10
Exact Sciences Corp. EXAS 17520 1712 5.22 -19.77 -49.89
PRA Health Sciences Inc PRAH 10739 3333 6.88 50.52 6.40
Syneos Health Inc SYNH 9843 4730 2.99 41.85 4.99
Medpace Holdings Inc MEDP 7069 1028 7.82 40.09 17.02
Vir Biotechnology Inc VIR 6957 183 9.62 -22.93 -162.74
Exelixis Inc EXEL 6651 1157 3.19 71.45 8.13
Twist Bioscience Corp TWST 5722 127 9.83 -43.48 -106.59
Allakos Inc ALLK 5677 10.33 -28.51 None
Sana Biotechnology Inc SANA 4654 5.33 -14.20 None
Recursion Pharmaceuticals Inc RXRX 4504 9 7.04 -36.73 None
Allogene Therapeutics Inc ALLO 3325 38 3.52 -13.87 -621.84
Alx Oncology Holdings Inc ALXO 3112 1 7.75 -26.83 -401.23
Lyell Immunopharma Inc LYEL 2956 8 2.90 -15.27 None
Verve Therapeutics Inc VERV 2874 7.09 -29.07 None
Cortexyme Inc CRTX 2634 18.33 -29.86 None
Instil Bio Inc TIL 2426 0 3.81 -29.39 None
Erasca Inc ERAS 2233 -15.66 -17.65 None
Sorrento Therapeutics Inc SRNE 2206 51 13.03 -6.97 -626.43
Organogenesis Holdings Inc ORGO 2099 433 11.99 27.77 16.17
Castle Biosciences Inc CSTL 1778 78 4.68 -76.55 -28.88
Rubius Therapeutics Inc RUBY 1734 7.11 -10.00 None
Replimune Group Inc REPL 1596 3.18 -17.71 None
Constellation Pharmaceuticals CNST 1564 4.32 -11.18 None
AlloVir Inc ALVR 1511 0 5.17 -12.83 -718.59
Pandion Therapeutics Inc PAND 1501 1069 1.83 -13.34 -10.55
Y-Mabs Therapeutics Inc YMAB 1431 37 6.18 -31.09 -114.04
Monte Rosa Therapeutics Inc GLUE 1383 4.00 -24.01 None
Scholar Rock Holding Corp SRRK 1377 16 6.44 -12.74 -687.82
Caribou Biosciences Inc CRBU 1351 5 -30.71 -26.71 -955.31
Century Therapeutics Inc IPSC 1337 3.01 -19.19 None
National Research Corp NRC 1244 140 15.94 34.16 25.62
Cullinan Oncology Inc CGEM 1162 19 2.53 -21.31 -284.59
Janux Therapeutics Inc JANX 1123 1 2.96 -97.82 -436.67
Graphite Bio Inc GRPH 1085 2.97 -22.01 None
Precigen Inc PGEN 1008 101 7.12 -9.13 -107.45
RAPT Therapeutics Inc RAPT 987 5 5.35 -16.45 7.14
Design Therapeutics Inc DSGN 889 0 2.22 -46.20 -245.44
Sutro Biopharma Inc STRO 838 69 3.00 -9.20 -114.69
Ideaya Biosciences Inc IDYA 833 36 4.29 -31.98 -84.49
Crinetics Pharmaceuticals Inc CRNX 775 0 4.46 -8.74 -447.78
Precision Biosciences Inc DTIL 705 101 7.45 -14.15 -45.88
Imago BioSciences Inc IMGO 681 -8.75 -26.15 None
Acumen Pharmaceuticals Inc ABOS 633 1 -6.19 -6.52 -550.91
Talaris Therapeutics Inc TALS 579 2.18 -17.02 None
Vor Biopharma Inc VOR 568 2.28 -8.68 None
MeiraGTx Holdings plc MGTX 554 19 2.91 -9.58 -325.95
Mirum Pharmaceuticals Inc MIRM 506 11 5.76 -3.33 None
Kezar Life Sciences Inc KZR 474 3.44 -9.89 None
Werewolf Therapeutics Inc HOWL 473 2.57 -2.54 None
Vera Therapeutics Inc VERA 472 5.19 -8.61 None
Aerovate Therapeutics Inc AVTE 464 -22.91 -31.50 None
Rallybio Corp RLYB 428 -6.39 -10.07 None
Evelo Biosciences Inc EVLO 409 7.19 -3.86 None
Magenta Therapeutics Inc MGTA 390 2.25 -5.60 None
Cue Biopharma Inc CUE 387 5 5.59 -8.97 -802.84
Applied Therapeutics Inc APLT 371 14 3.32 -3.25 -19.41
Black Diamond Therapeutics Inc BDTX 342 1.37 -3.25 None
Oyster Point Pharma Inc OYST 341 2.25 -4.27 None
Pieris Pharmaceuticals Inc PIRS 333 24 8.36 -6.88 -203.73
Luna Innovations Inc LUNA 329 101 4.07 142.29 2.46
Biomea Fusion Inc BMEA 318 1.58 -16.89 None
Surface Oncology Inc SURF 305 90 2.18 13.65 18.99
Sensei Biotherapeutics Inc SNSE 301 1.82 -10.57 None
Cabaletta Bio Inc CABA 297 3.05 -7.64 None
Impel NeuroPharma Inc. IMPL 274 5.49 -5.66 None
Sera Prognostics Inc SERA 257 0 -1.79 -10.92 None
INmune Bio Inc INMB 257 0 7.58 -13.19 None
AquaBounty Technologies Inc AQB 243 0 1.38 -11.92 None
Elevation Oncology Inc ELEV 224 1.46 -10.06 None
Alzamend Neuro Inc ALZN 221 130.00 -43.33 None
Compass Therapeutics Inc CMPX 220 7.55 -2.71 None
Gemini Therapeutics Inc GMTX 211 1088 0.23 1.74 11.24
Hookipa Pharma Inc HOOK 202 20 1.60 -3.30 -304.07
Candel Therapeutics Inc CADL 196 0 -5.23 -5.64 None
Nextcure Inc NXTC 196 22 0.73 -2.90 -163.57
Reneo Pharmaceuticals Inc RPHM 192 1.16 -7.00 None
Unity Biotechnology Inc UBX 164 1 2.52 -2.02 None
Tscan Therapeutics Inc TCRX 150 6 -2.50 -4.36 -563.14
IN8bio Inc INAB 133 -6.19 -13.21 None
Exicure Inc XCUR 124 4 3.36 -2.61 -148.49
HCW Biologics Inc HCWB 123 4 -5.58 -19.11 -162.03
Axcella Health Inc AXLA 120 2.56 -2.14 None
Cyclerion Therapeutics Inc CYCN 106 4 2.07 -1.58 None
Scopus Biopharma Inc SCPS 98 234 -49.36 -4.64 80.93
BioVie Inc BIVI 90 37.60 -0.51 None
Eloxx Pharmaceuticals Inc ELOX 88 0 3.98 -1.61 -14.14
CohBar Inc CWBR 67 6.05 -3.97 None
Monopar Therapeutics Inc MNPR 63 2.83 -7.98 None
Rezolute Inc RZLT 57 2.36 -3.18 None
Vaccinex Inc VCNX 55 1 4.15 -1.95 -48.71
Acurx Pharmaceuticals Inc ACXP 46 2.99 -5.72 None
Cytocom Inc CBLI 41 0 5.41 -17.72 -912.16
Cyclo Therapeutics Inc CYTH 41 1 3.94 -1.95 -989.80
Synaptogenix Inc SNPX 41 1.29 -2.70 None
NanoViricides Inc NNVC 40 1.45 -7.05 None
Aridis Pharmaceuticals Inc ARDS 40 0 -4.37 -1.61 -851.00
Unicycive Therapeutics Inc UNCY 39 -9.69 -10.81 None
AgeX Therapeutics Inc AGE 38 2 -4.59 -4.04 -522.77
TransCode Therapeutics Inc RNAZ 29 -6.23 -8.38 None
Kiromic BioPharma Inc KRBP 24 10.81 -1.72 None
Xenetic Biosciences Inc XBIO 19 1 2.30 -1.43 -47.40
Geovax Labs Inc GOVX 19 1 1.52 -13.03 -558.09
Tenax Therapeutics Inc TENX 15 0 22.83 -0.59 -840.64
Neurotrope Inc NTRP 5 29 0.08 0.76 23.48

Replimune Group Inc REPL

5d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

A Look At The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)

15d ago, source: Nasdaq

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Replimune Group, Inc. (NASDAQ:REPL) as an investment opportunity by taking the expected future cash ...

Novavax Inc. stock outperforms competitors despite losses on the day

9d ago, source: MarketWatch

Shares of Novavax Inc. shed 1.40% to $266.80 Wednesday, on what proved to be an all-around dismal trading session for the ...

Replimune Group Inc (REPL): Price Now Near $31.9; Daily Chart Shows Downtrend on 50 Day Basis

17d ago, source: ETF Daily News

Currently, REPL (Get Ratings)’s price is up $0.04 (0.13%) from the hour prior. It’s been a feast for bulls operating on an hourly timeframe, as REPL has now gone up 4 of the past 5 hours. If ...

Replimune Group Inc. Registered (7R8.SG)

23d ago, source: Yahoo Finance

Stocks turn lower: Dow drops 100+ points, or 0.3%, while Nasdaq and S&P 500 retreat from record highs ...

10 Biggest Price Target Changes For Monday

23d ago, source: Yahoo Finance

Synaptics shares rose 2.1% to close at $169.59 on Friday. SVB Leerink lowered Replimune Group, Inc. (NASDAQ: REPL) price target from $55 to $49. Replimune shares rose 4.1% to close at $30.17 on ...

Replimune Group Inc.

5d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Replimune Group Inc (REPL): Price Now Near $30.17; Daily Chart Shows Downtrend on 50 Day Basis

1mon ago, source: ETF Daily News

At the moment, REPL (Get Ratings)’s price is up $0.74 (2.5%) from the hour prior. It’s been a feast for bears operating on an hourly timeframe, as REPL has now gone down 8 of the past 10 hours ...

Replimune Group Inc REPL

8d ago, source: Morningstar%2c Inc.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Your Portfolio